245 related articles for article (PubMed ID: 32569239)
1. Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.
Yu R; Nansubuga F; Yang J; Ding W; Li K; Weng D; Wu P; Chen G; Ma D; Wei J
Medicine (Baltimore); 2020 Jun; 99(25):e20928. PubMed ID: 32569239
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of argatroban versus heparin for preventing venous thromboembolism after lumbar decompressive surgery.
Guo Y; Zou Z; Jia L; Huang Z; Yun X; Xing G
Int J Surg; 2017 Aug; 44():324-328. PubMed ID: 28694001
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G;
Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery.
Dainty L; Maxwell GL; Clarke-Pearson DL; Myers ER
Gynecol Oncol; 2004 May; 93(2):366-73. PubMed ID: 15099947
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery.
Maxwell GL; Myers ER; Clarke-Pearson DL
Obstet Gynecol; 2000 Feb; 95(2):206-14. PubMed ID: 10674581
[TBL] [Abstract][Full Text] [Related]
6. [Perioperative intervention to prevent lower extremity deep venous thrombosis after gynecologic surgery].
Zhu ZJ; Fang SH; Wang MZ; Lou HY; Shu J; Ying KJ
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):669-72. PubMed ID: 20079178
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of preventive treatment of thrombosis for patients undergoing gynecological surgery with high risk factors].
Yang BL; Zhang ZY; Guo SL
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):570-3. PubMed ID: 20003782
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
[TBL] [Abstract][Full Text] [Related]
9. High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
Groot OQ; Ogink PT; Paulino Pereira NR; Ferrone ML; Harris MB; Lozano-Calderon SA; Schoenfeld AJ; Schwab JH
Clin Orthop Relat Res; 2019 Jul; 477(7):1674-1686. PubMed ID: 31135550
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
11. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
12. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
13. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
[TBL] [Abstract][Full Text] [Related]
16. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery.
Wright JD; Chen L; Jorge S; Burke WM; Tergas AI; Hou JY; Hu JC; Neugut AI; Ananth CV; Hershman DL
Gynecol Oncol; 2016 Jun; 141(3):531-537. PubMed ID: 27032377
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
18. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: A systematic review and network meta-analysis.
Insin P; Vitoopinyoparb K; Thadanipon K; Charakorn C; Attia J; McKay GJ; Thakkinstian A
Gynecol Oncol; 2021 Apr; 161(1):304-313. PubMed ID: 33563489
[TBL] [Abstract][Full Text] [Related]
20. Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery.
Wei N; Qi Y; Yang H; Guo L
Pak J Pharm Sci; 2018 Nov; 31(6(Special)):2835-2839. PubMed ID: 30630795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
